Undoubtedly, the pharmaceutical industry is one of the global economy’s most complex yet essential sectors. With the need for high-quality drugs and treatments becoming increasingly important, the demand for APIs (Active Pharmaceutical Ingredients) has never been higher. As such, it is essential to source these APIs from reliable and reputable suppliers. This blog will discuss the world’s top 10 API pharma companies.
1. Lonza Group
Lonza Group is a global leader in the manufacturing of APIs and biopharmaceuticals. With over 125 years of experience, Lonza has one of the largest portfolios of APIs for therapeutic areas. As a preferred global partner to the pharmaceutical, biotech, and nutrition markets, Lonza offers solutions that improve life quality by preventing illness and supporting treatments. Smaller companies can benefit from Lonza’s expertise in bringing their candidates to market without building in-house manufacturing capacity or the full range of knowledge.
In 2019, Lonza spent $518 million on a new large-scale fill-finish manufacturing plant, furthering its commitment to providing leading healthcare solutions. Teva’s joint venture with Lonza combines their combined knowledge of clinical development and marketing of generic pharmaceuticals that generate significant returns. You can trust Lonza for small molecules like active pharmaceutical ingredients (API) and antibody-drug conjugates.
You can trust Pfizer to develop, manufacture, and market high-quality APIs that help treat cardiovascular, metabolic, and pain-related conditions. Through its CentreOne® contract development and manufacturing organization (CDMO), Pfizer can partner with external organizations that share in their purpose of delivering revolutionary treatments.
Additionally, Pfizer invests in emerging companies that show the potential to enhance the company’s pipeline. Pfizer is a market leader in the global pain treatment industry, having registered $6.4bn in sales in 2010. The company strives to apply science and resources to bring therapies that extend and significantly improve lives.
With a focus on the pharmaceutical industry, Pfizer has plans for long-term growth in the sector and has already established itself as a leader. The company also provides post-authorization experience by June 18th, 2022, and has set February 28th, 2022, as the date for its safety database for non-CT dataset.3. GlaxoSmithKline
3. Sun Pharma Industries
Sun Pharmaceutical Industries Ltd. is a global specialty pharmaceutical company with a presence in more than 150 countries. Founded in 1983, Sun Pharma is the fourth largest generic pharmaceutical company globally, with over US$5 billion in global revenues. The company produces a comprehensive, diverse, and highly complementary portfolio of generic and specialty medicines targeting a wide spectrum of chronic and acute therapeutic areas.
Sun Pharma has been present in the United States since 1996, providing high-quality healthcare products to its customers. The company’s mission is to create value for patients worldwide through rapid access to affordable medicines. Mr. Dilip Shanghvi has been a director of Sun Pharma since its inception and is also on the board of Taro Pharmaceuticals Ltd.
Merck has been an industry leader in the pharmaceuticals market since its founding in 1668. As one of the world’s largest and most profitable companies, Merck has developed innovative therapies for multiple therapy areas, including cardiovascular, diabetes, oncology, and neurology. Merck’s legacy of innovation has made it a leader in biopharmaceuticals, with over $48 billion in revenues in 2021.
With a world-class research and development program, Merck continues to develop new treatments that help people around the globe. At Torreya Partners, we are proud to provide strategic advice to many companies in the global generic industry that partner with Merck.
You can rely on Sanofi for your therapeutic needs. Their APIs are used for treating diabetes, cardiovascular and infectious diseases and are of the highest quality. Sanofi appointed Karl Rotthier as the EUROAPI leader and established Opella Healthcare International SAS in Beijing’s Economic & Technological Development Area to secure significant API manufacturing and supply capacities to ensure their products are up-to-date.
Additionally, they have 16 chemistry, biochemistry, and biotechnical facilities dedicated to producing high-quality APIs and advanced drug delivery systems. With Sanofi’s commitment to Corporate Social Responsibility (CSR), you can be sure that you’re getting a reliable product from a reputable company.
Novartis is a global healthcare company dedicated to providing solutions that address the changing needs of patients. The company produces APIs for various therapeutic areas, including oncology, respiratory, cardiovascular, and ophthalmology. It also develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars, and ophthalmic products.
In 2021, Novartis achieved a solid performance due to strong demand for its heart failure medicine Entresto and other products. Its Sandoz segment is one of the world’s largest manufacturers of generic drugs and APIs. Unique products from Novartis include methylphenidate (Ritalin) and its COVID-19 vaccine candidate. The company’s portfolio strategy has gained broad support from major pharmaceutical companies investing in innovative projects.
7. Teva Pharmaceutical Industries
At Teva Pharmaceuticals, their mission is to be a global leader in generics and biopharmaceutical medicines, providing quality treatments to improve the lives of patients around the world. They offer the world’s giant medicine cabinet, with a full spectrum of products from generics, APIs, and over-the-counter products to specialty medicines. Their core therapeutic areas include respiratory conditions, pain, headaches and migraine, cancer, and central nervous system (CNS) medicines such as Copaxone.
Teva has been dedicated to bringing quality medicines to the world since 1901. We are currently the leading international supplier of active pharmaceutical ingredients (API), with an industry-leading portfolio of more than 350 products. In Generics, we have developed products in all therapeutic areas and are well-positioned in the global pharmaceutical industry.
Teva Pharmaceuticals Limited is listed on the Israeli Securities Law and has no non-voting common equity. Their commitment to improving patient lives is reflected in our position as the leading generic drug company in the United States and Europe.
AstraZeneca is a global, science-led biopharmaceutical company that creates innovative medicines for millions of patients worldwide. The company focuses on developing treatments and vaccines for oncology, cardiovascular and metabolic diseases, respiratory illnesses, inflammation and autoimmune diseases, infections, and neurological disorders. AstraZeneca has headquarters at the Cambridge Biomedical Campus in the UK and has a presence in Australia. The company is dedicated to researching, developing, manufacturing, and delivering transformative medicines that make a meaningful difference in people’s lives.
Mylan is a global leader in manufacturing active pharmaceutical ingredients (APIs) for various therapeutic areas. Mylan is particularly well-known for its production of APIs used to treat diabetes and cardiovascular and infectious diseases. The company operates one of India’s largest API manufacturing platforms, including oral solid dose (OSD) and injectables production facilities. Mylan also produces anti-retroviral therapy (ARV) products for people living with HIV/AIDS and markets APIs to third parties worldwide.
The company was founded in 1961 and headed by the Chief Executive Officer of Centrient Pharmaceuticals, who had over 29 years of experience in international business. Mylan works to make Novartis an industry leader and follows International Financial Reporting Standards (IFRS).
10. Boehringer Ingelheim
Boehringer Ingelheim is a research-driven pharmaceutical company with over 130 years of experience. Founded in 1885, it is a family-owned business with three business areas: Human Pharma, Animal Health, and Biopharmaceuticals. It has become a global enterprise with products that improve lives in multiple therapeutic areas such as oncology, respiratory and insulin-dependent diabetes.
The company also provides clinical development and medical affairs fellowships for post-doctoral pharmacists. Boehringer Ingelheim strives to create value through innovation in areas of high unmet medical need. The company continually works to strengthen its research pipeline and plans for the long term.
The aforementioned companies are some of the world’s most renowned and reliable API suppliers. To ensure that you source APIs of the highest quality, it is essential to source them from a company with a proven track record of excellence. By researching the aforementioned companies, and others, you can be sure to source the best APIs available.